NEW YORK (Reuters Health) – Patients with pulmonary arterial hypertension (PAH) receiving the endothelin A selective antagonist ambrisentan (Letairis, Gilead) no longer need monthly liver function tests. However,…
NEW YORK (Reuters Health) – The combination of estrogen and raloxifene seems to reduce menopausal symptoms and appears not to increase the risk of endometrial hyperplasia, researchers from…
NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who…
NEW YORK (Reuters Health) – Giving adolescent mothers postpartum contraceptive implants is an effective curb on further pregnancies within a year, researchers report in an April 18th on-line…
Recent studies show that sales and deaths related to opiate pain relievers have quadrupled over the last decade in the United States. Also, illicit drug use among pregnant…
NEW YORK (Reuters Health) – The sedative effects of benzodiazepine exposure through breast milk appear to present minimal risk of central nervous system (CNS) depression in infants, results…
NEW YORK (Reuters Health) – When testing indicates fetal lung immaturity at 34 weeks’ gestation or more, administration of antenatal corticosteroids does not reduce respiratory problems in the…
NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in…
NEW YORK (Reuters Health) – A combined oral contraceptive containing nomegestrol acetate and 17beta-estradiol (E2) taken in a 24–4-day regimen is somewhat more effective in preventing pregnancy than…
NEW YORK (Reuters Health) – The likelihood of small bowel obstruction (SBO) developing because of adhesions following abdominal or pelvic surgery is generally lower with laparoscopic procedures than…